Hyle Emily P, Le Mylinh H, Rao Sowmya R, Mulroy Nora M, Walker Allison T, Ryan Edward T, LaRocque Regina C
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Open Forum Infect Dis. 2022 Aug 3;9(8):ofac399. doi: 10.1093/ofid/ofac399. eCollection 2022 Aug.
To assess the implications of coronavirus disease 2019 (COVID-19)-related travel disruptions, we compared demographics and travel-related circumstances of US travelers seeking pretravel consultation regarding international travel at US Global TravEpiNet (GTEN) sites before and after the initiation of COVID-19 travel warnings.
We analyzed data in the GTEN database regarding traveler demographics and travel-related circumstances with standard questionnaires in the pre-COVID-19 period (January-December 2019) and the COVID-19 period (April 2020-March 2021), excluding travelers from January to March 2020. We conducted descriptive analyses of differences in demographics, travel-related circumstances, routine and travel-related vaccinations, and medications.
Compared with 16 903 consultations in the pre-COVID-19 period, only 1564 consultations were recorded at GTEN sites during the COVID-19 period (90% reduction), with a greater proportion of travelers visiting friends and relatives (501/1564 [32%] vs 1525/16 903 [9%]), individuals traveling for >28 days (824/1564 [53%] vs 2522/16 903 [15%]), young children (6 mo-<6 y: 168/1564 [11%] vs 500/16 903 [3%]), and individuals traveling to Africa (1084/1564 [69%] vs 8049/16 903 [48%]). A smaller percentage of vaccine-eligible travelers received vaccines at pretravel consultations during the COVID-19 period than before, except for yellow fever and Japanese encephalitis vaccinations.
Compared with the pre-COVID-19 period, a greater proportion of travelers during the COVID19 period were young children, were planning to visit friends and relatives, were traveling for >28 days, or were traveling to Africa, which are circumstances that contribute to high risk for travel-related infections. Fewer vaccine-eligible travelers were administered travel-related vaccines at pretravel consultations. Counseling and vaccination focused on high-risk international travelers must be prioritized during the COVID-19 pandemic.
为评估2019冠状病毒病(COVID-19)相关旅行中断的影响,我们比较了在COVID-19旅行警告发布前后,在美国全球旅行疫情监测网络(GTEN)站点寻求国际旅行前咨询的美国旅行者的人口统计学特征和与旅行相关的情况。
我们分析了GTEN数据库中,关于旅行者人口统计学特征和与旅行相关情况的数据,使用COVID-19之前(2019年1月至12月)和COVID-19期间(2020年4月至2021年3月)的标准问卷,排除2020年1月至3月的旅行者。我们对人口统计学特征、与旅行相关的情况、常规和与旅行相关的疫苗接种以及药物方面的差异进行了描述性分析。
与COVID-19之前的16903次咨询相比,GTEN站点在COVID-19期间仅记录了1564次咨询(减少了90%),其中拜访朋友和亲戚的旅行者比例更高(501/1564 [32%] 对1525/16903 [9%]),旅行超过28天的个人(824/1564 [53%] 对2522/16903 [15%]),幼儿(6个月至<6岁:168/1564 [11%] 对500/16903 [3%]),以及前往非洲的个人(1084/1564 [69%] 对8049/16903 [48%])。在COVID-19期间,符合疫苗接种条件的旅行者在旅行前咨询中接受疫苗接种的比例低于之前,黄热病和日本脑炎疫苗接种除外。
与COVID-19之前相比,COVID-19期间更大比例的旅行者是幼儿,计划拜访朋友和亲戚,旅行超过28天,或前往非洲,这些情况会增加与旅行相关感染的高风险。在旅行前咨询中,接受与旅行相关疫苗接种的符合疫苗接种条件的旅行者减少。在COVID-19大流行期间,必须优先为高风险国际旅行者提供咨询和疫苗接种。